“…A number of effector cells includ ing subpopulations of lymphocytes [Nel son et al, 1976;Sandilans et al, 1976;Evans et al, 1978], monocyte-macrophage cells [Mantovani et al, 1977] and neutro phils [Hafeman and Lucas, 1979] have been shown to mediate ADCC. Recently, several workers described the decreased ADCC potential of the peri pheral blood from patients with different types of leukemia [Faldt and Ankerst, 1979;, Fernandes et al, 1979;Platsoucas et al, 1980;Jakobisiak et al, 1981a], cancer [Stratton et al, 1977] and primary immu nodeficiency disorders [Karen et al, 1978].…”